Showing 1811-1820 of 9404 results for "".
First Reported Case of Red Face Response to Tralokinumab in the United States
https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/The chronic nature of atopic dermatitis (AD), which currently affects approximately 10.8% of children and 7.3% of adults in the United States,1 makes long-term management challenging.The View from Under the Hood
https://practicaldermatology.com/issues/january-february-2025/the-view-from-under-the-hood/32967/As 2025 brings new approvals for treatments for hidradenitis suppurativa, chronic spontaneous urticaria, psoriatic arthritis, and several other diseases that need answers, this is a good time for us to remember that the most important approach to treatment starts with the right diagnosis.An Exciting Integration of Two Cosmetic Conferences
https://practicaldermatology.com/topics/editorial/exciting-integration-two-cosmetic-conferences/28865/After 13 years of running Cosmetic Surgery Forum on my own, I am excited to announce the integration of Cosmetic Surgery Forum into the Multispecialty Aesthetic Conference (MAC), to be held in Hilton Head from March 27-30, 2025 at the oceanfront Westin Hilton Head Island Resort.Embrace Your Curiosity: The Power of Questions
https://practicaldermatology.com/topics/practice-management/embrace-your-curiosity-the-power-of-questions/24031/Asking empowering questions may yield more creative answers.PASI-HD: New Method for Measuring Severity in Mild to Moderate Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/pasi-hd-new-method-for-measuring-severity-in-mild-to-moderate-plaque-psoriasis/20185/Robert Higham, MPAS, PA-C, Executive Director of Clinical Development of Arcutis Biotherapeutics, discusses PASI-HD, a new measure designed to assess severity and therapeutic response in patients with mild and moderate psoriasis. PASI High Discrimination (PASI-HD) was developed to better understandFighting for Change
https://practicaldermatology.com/topics/practice-management/fighting-for-change/23775/Unpacking the new AMA Recovery Plan for America’s physicians.Current Unmet Needs in Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/current-unmet-needs-in-plaque-psoriasis/20098/Patrick Burnett, Chief Medical Officer of Arcutis Biotherapeutics, discusses new insights from a national survey on the psychosocial impact of plaque psoriasis and the current unmet need for topical therapies for plaque psoriasis. These data reinforce that psychosocial wellbeing can be just as imporProtect Yourself and Your Family with Effective Estate Planning
https://practicaldermatology.com/topics/practice-management/protect-yourself-and-your-family-with-effective-estate-planning/23727/Estate planning is an essential part of preserving and distributing your assets in the future.Herbals in the Holistic Treatment of Psoriasis: An Update
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis-an-update/23716/As interest in herbals increases, dermatologists should be aware of commonly used agents.From Hopelessness to Hope
https://practicaldermatology.com/topics/practice-management/from-hopelessness-to-hope/23657/New legislation aims to prevent physician suicide and burnout.